R0Z Stock Overview
Develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
Redsense Medical AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 0.54 |
| 52 Week High | SEK 0.73 |
| 52 Week Low | SEK 0.38 |
| Beta | 0.51 |
| 11 Month Change | -5.28% |
| 3 Month Change | 1.13% |
| 1 Year Change | -16.98% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -30.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| R0Z | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0.7% | 2.4% | 0.8% |
| 1Y | -17.0% | -5.0% | 9.1% |
Return vs Industry: R0Z underperformed the German Medical Equipment industry which returned -6.8% over the past year.
Return vs Market: R0Z underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| R0Z volatility | |
|---|---|
| R0Z Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 5.5% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.8% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: R0Z's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: R0Z's weekly volatility (9%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2000 | 5 | Sebastien Bollue | redsensemedical.com |
Redsense Medical AB (publ) develops, markets, and sells monitoring systems for medical treatments primarily in Europe and the United States. The company offers Redsense System, a medical technology product that is used for monitoring and alarming in the event of blood leakage in connection with a hemodialysis treatment. It also provides Redsense Clamp, which clamps the bloodline to stop blood flow when the alarm unit detects a blood leakage.
Redsense Medical AB (publ) Fundamentals Summary
| R0Z fundamental statistics | |
|---|---|
| Market cap | €10.69m |
| Earnings (TTM) | -€344.59k |
| Revenue (TTM) | €2.12m |
5.0x
P/S Ratio-31.0x
P/E RatioIs R0Z overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| R0Z income statement (TTM) | |
|---|---|
| Revenue | SEK 24.49m |
| Cost of Revenue | SEK 10.13m |
| Gross Profit | SEK 14.36m |
| Other Expenses | SEK 18.33m |
| Earnings | -SEK 3.98m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
Nov 26, 2024
| Earnings per share (EPS) | -0.24 |
| Gross Margin | 58.63% |
| Net Profit Margin | -16.24% |
| Debt/Equity Ratio | 0% |
How did R0Z perform over the long term?
See historical performance and comparison